More on COLL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $23.18 |
|
|||
| Open | $23.40 | ||||
| 52 Wk High | $30.58 | ||||
| 52 Wk Low | $8.24 | ||||
| Day High | $23.41 | ||||
| Day Low | $22.86 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 558,737 | ||||
- Form SCHEDULE 13G/A COLLEGIUM PHARMACEUTICAL Filed by: INTEGRATED CORE STRATEGIES (US) LLC
- Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
- Collegium Launches "Start Talking ADHD" with Practical Support to Help Families Navigate Care, School and Everyday Life
- Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dreyer Scott
- Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
- Leerink Starts Collegium Pharmaceutical (COLL) at Outperform
- Truist Securities Assumes Collegium Pharmaceutical (COLL) at Buy
- Collegium to Participate in Upcoming Investor Conferences
- Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: INTEGRATED CORE STRATEGIES (US) LLC
- Barclays flags an "attractive entry point" in this pharma stock
Entities mentioned with COLL
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- Needham & Company | View Related Stories »
- Stock Buyback | View Related Stories »
- Piper Jaffray | View Related Stories »
- Show More...
